Search

everythinglearnresearchcommunity

for

Search:↓

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Some alternative medicine treatments might work for skin conditions, but their effectiveness and safety differ a lot.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

People with Behçet's disease can develop life-threatening lung artery aneurysms that may require surgery.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Gray hair can potentially be reversed, leading to new treatments.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

TNF-alpha inhibitors can cause various immune-related skin issues.

Stem cells could improve hair growth and new treatments for baldness are being researched.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

ALDOA levels drop in hair cells during hair loss.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

Ozone and procaine boost the release of healing factors in platelet-rich plasma.

PCOS is linked to low-grade chronic inflammation.

TLR2 is important for hair growth and can be targeted to treat hair loss.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

New cytokine-targeted therapies show promise for treating alopecia areata.